岭南万应品牌怎么样 申请店铺

我要投票 岭南万应在医疗器械行业中的票数:111 更新时间:2025-02-23
岭南万应是哪个国家的品牌?「岭南万应」是 广东富晖药业有限公司 旗下著名品牌。该品牌发源于新加坡,由创始人区可亭在2005-07-01期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力岭南万应品牌出海!通过在本页面挂载岭南万应品牌的产品链接和联系邮箱,可以提高岭南万应产品曝光!跨境电商爆单神器,目前只要100元/年哦~

岭南万应怎么样

一九一九年,始创人吕满昌先生于新加坡创制紅花油等各种外用药品。直至五十年代移师香港,其子吕泳沂先生创办岭南药厂。岭南药厂均以真材实料,制作严谨,绝不取巧为经营宗旨;不断创新的精神,研制出用途广泛,气味清新之「岭南万应止痛膏」及「岭南万应荳蔻膏」。每一产品均严格选料,炮制,并遵循古方炼制而成。产品除畅销香港、台湾、中国大陆及东南亚新加坡、越南、马来西亚等地,还覆盖美国东西两岸,以至澳州,欧洲等国家。

为了扩大香港及中国大陆市场,岭南药厂(香港)有限公司已根据国际卫生组织标准的优良制药规范(G.M.P)改造厂房,控制生产管理及产品流程,购买岭南药厂产品的消费者,得到优良的产品。岭南药厂(香港)有限公司分别于2000年在香港成立岭峰贸易有限公司及2005年在国内成立广东富晖药业有限公司的子公司。

岭峰贸易有限公司成立至今,已建立广泛而稳健的销售网络,公司拥有一支精英销售团队,服务全港各主要药房、药店及分销商,目前已达成全港药店和连锁店基本覆盖配送。岭峰贸易主要代理及经销各厂家的产品,除母公司岭南药厂全线产品外,还有余仁生系列产品、澳门张权破痛油产品、京都念慈奄产品、天喜堂天喜丸、太和洞久咳丸等产品。

产品的销售网络覆盖了全国各地的主要省份城市,深受消费者欢迎。为结合市场发展需要、更好地维护好市场,建立集渠道销售、零售终端维护、终端督导监控、专业医药人员推广的产品销售与品牌推广隊伍。除了传统销售模式外,还加入直接面向药店店员及社区消费者的专业产品品牌推广隊伍,使产品能够以专业人员用直接有效方式向授众推广。


In 1919, Mr. LV Manchang, the founder, created various kinds of external medicines in Singapore, such as safflower oil. Until he moved to Hong Kong in the 1950s, his son Mr. LV Yongyi established Lingnan pharmaceutical factory. Lingnan Pharmaceutical Co., Ltd. is committed to the business purpose of making precise materials and never taking advantage of them. With the spirit of continuous innovation, it has developed "Lingnan WANYING painkiller cream" and "Lingnan WANYING cardamom cream" with a wide range of uses and fresh smell. Each product is strictly selected materials, processing, and follow the ancient refining. Our products not only sell well in Hong Kong, Taiwan, mainland China, Southeast Asia, Singapore, Vietnam, Malaysia and other places, but also cover the East and west sides of the United States, as well as Australia, Europe and other countries. In order to expand the market in Hong Kong and Mainland China, Lingnan Pharmaceutical (Hong Kong) Co., Ltd. has transformed its factory building in accordance with the good pharmaceutical practice (g.m.p) of the International Health Organization standard, controlled its production management and product process, purchased the consumers of Lingnan pharmaceutical products, and obtained excellent products. Lingnan Pharmaceutical (Hong Kong) Co., Ltd. established Lingfeng Trading Co., Ltd. in Hong Kong in 2000 and Guangdong Fuhui Pharmaceutical Co., Ltd. in 2005. Since its establishment, Lingfeng Trading Co., Ltd. has established a wide and stable sales network. The company has an elite sales team to serve major pharmacies, pharmacies and distributors in Hong Kong. At present, it has reached the basic coverage of pharmacies and chain stores in Hong Kong. Lingfeng trade mainly acts as an agent for and sells products of various manufacturers. In addition to the products of Lingnan pharmaceutical factory, the parent company, there are products of Yu Rensheng series, products of Zhang Quan breaking pain oil in Macao, products of Kyoto nianciyan, tianxitang Tianxi pill, Taihe Dongjiu cough pill, etc. The sales network of the products covers the major provinces and cities all over the country, and is popular with consumers. In order to meet the needs of market development and better maintain the market, establish a product sales and brand promotion team that integrates channel sales, retail terminal maintenance, terminal supervision and monitoring, and professional medical personnel promotion. In addition to the traditional sales model, we also joined the professional product brand promotion team directly facing the drugstore staff and community consumers, so that the products can be promoted to the audience in a direct and effective way by professionals.

本文链接: https://brand.waitui.com/016a75eb4.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

天岳先进:2024年净利润1.8亿元 同比扭亏为盈

36氪获悉,天岳先进发布业绩快报,公司2024年实现营业收入17.68亿元,同比增长41.37%;实现归属于母公司所有者的净利润1.80亿元,同比扭亏为盈。主要原因是公司大尺寸、导电型产品产能产量持续提升,销售量增加,同时产品毛利率上升。

2小时前

小米集团卢伟冰:小米15 Ultra会是越级式的一代产品

36氪获悉,小米集团合伙人兼总裁、手机部总裁、小米品牌总经理卢伟冰发文称,小米手机未来5年高端化的目标之一,就是要在6000元+价格段实现规模化的突破,“Ultra是6K+突破的关键产品,而小米15 Ultra会是越级式的一代产品”。

2小时前

恒瑞医药:羟乙磺酸达尔西利片联合内分泌治疗乳腺癌III期临床试验达主要终点

36氪获悉,恒瑞医药公告称,公司自主研发的羟乙磺酸达尔西利片在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性女性乳腺癌辅助治疗的III期临床试验中,首次期中分析主要终点达到统计学显著性。研究结果显示,达尔西利联合内分泌治疗可显著降低患者复发风险,提高患者无侵袭性疾病生存期(IDFS)。公司已向国家药品监督管理局药品审评中心递交上市前沟通交流申请。该药品是公司自主研发的化学药品1类新药,是一种口服、高效、选择性的小分子CDK4/6抑制剂。

2小时前

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

2小时前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2小时前

本页详细列出关于海氏海诺的品牌信息,含品牌所属公司介绍,海氏海诺所处行业的品牌地位及优势。
咨询